An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss-Reference-Cited by-同舟云学术

An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss

Published:2008-09 Issue: Volume:201-202 Page:200-211
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Hampton David W.,Anderson Jane,Pryce Gareth,Irvine Karen-Amanda,Giovannoni Gavin,Fawcett James W.,Compston Alastair,Franklin Robin J.M.,Baker David,Chandran Siddharthan

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference56 articles.

1. A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis: inflammation versus degeneration;Ahmed;Am. J. Pathol.,2002

2. Vesicular glutamate transporters in the spinal cord, with special reference to sensory primary afferent synapses;Alvarez;J. Comp. Neurol.,2004

3. Biozzi mice: of mice and human neurological diseases;Amor;J. Neuroimmunol.,2005

4. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination;Arnett;Nat. Neurosci.,2001

5. bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS;Arnett;Science,2004

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CNS myeloid infiltrates provides neuroprotection in a progressive multiple sclerosis model;Brain, Behavior, and Immunity;2024-11

2. Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study;CNS Drugs;2024-09-06

3. Remyelination in the Central Nervous System;Cold Spring Harbor Perspectives in Biology;2024-02-05

4. Hallmarks of spinal cord pathology in multiple sclerosis;Journal of the Neurological Sciences;2024-01

5. Bruton’s tyrosine kinase inhibition reduces disease severity in a model of secondary progressive autoimmune demyelination;Acta Neuropathologica Communications;2023-07-12